绝经后妇女骨质疏松症的诊断和管理欧洲指南摘要
Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
机构信息
Centre for Metabolic Bone Diseases, University of Sheffield, University of Sheffield Medical School, Sheffield, UK.
Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia.
出版信息
Calcif Tissue Int. 2019 Mar;104(3):235-238. doi: 10.1007/s00223-018-00512-x.
Abstract
A guidance on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis was recently published in Osteoporosis International as a joint effort of the International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (Kanis et al. in Osteoporos Int https://doi.org/10.1007/s00198-018-4704-5 , 2018). This manuscript updates the previous guidelines document, published in 2013 (Kanis et al. in Osteoporos Int 24:23-57, 2013) and is written in a European perspective. The present article reports and summarizes the main recommendations included in this 2018 guidance document.
摘要
最近，国际骨质疏松基金会和欧洲临床与经济骨质疏松和骨关节炎学会在《骨质疏松国际》杂志上联合发表了一份关于评估和治疗因骨质疏松症而骨折风险的绝经后妇女的指南。该指南是对 2013 年发布的上一份指南文件的更新（Kanis 等人在《骨质疏松国际》24:23-57，2013），并从欧洲角度撰写。本文报告并总结了 2018 年这份指导文件中的主要建议。
相似文献
1
Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women.绝经后妇女骨质疏松症的诊断和管理欧洲指南摘要
Calcif Tissue Int. 2019 Mar;104(3):235-238. doi: 10.1007/s00223-018-00512-x.
2
Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women.绝经后妇女骨质疏松症的诊断和管理的欧洲指南执行摘要。
Aging Clin Exp Res. 2019 Jan;31(1):15-17. doi: 10.1007/s40520-018-1109-4. Epub 2019 Jan 5.
3
European guidance for the diagnosis and management of osteoporosis in postmenopausal women.欧洲绝经后妇女骨质疏松症的诊断和管理指南。
Osteoporos Int. 2019 Jan;30(1):3-44. doi: 10.1007/s00198-018-4704-5. Epub 2018 Oct 15.
4
European guidance for the diagnosis and management of osteoporosis in postmenopausal women.欧洲绝经后妇女骨质疏松症的诊断和管理指南。
Osteoporos Int. 2013 Jan;24(1):23-57. doi: 10.1007/s00198-012-2074-y. Epub 2012 Oct 19.
5
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.骨质疏松性骨折低、高和极高风险患者的管理算法。
Osteoporos Int. 2020 Jan;31(1):1-12. doi: 10.1007/s00198-019-05176-3. Epub 2019 Nov 13.
6
European guidance for the diagnosis and management of osteoporosis in postmenopausal women.欧洲绝经后女性骨质疏松症诊断与管理指南。
Osteoporos Int. 2008 Apr;19(4):399-428. doi: 10.1007/s00198-008-0560-z. Epub 2008 Feb 12.
7
Diagnosis and management of osteoporosis in postmenopausal women in Gulf Cooperation Council (GCC) countries: consensus statement of the GCC countries' osteoporosis societies under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).海湾合作委员会（GCC）国家绝经后妇女骨质疏松症的诊断和管理：在欧洲临床和经济骨质疏松症和骨关节炎学会（ESCEO）的支持下，GCC 国家骨质疏松症学会的共识声明。
Arch Osteoporos. 2020 Jul 22;15(1):109. doi: 10.1007/s11657-020-00778-5.
8
Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm.基于 FRAX 算法的巴泽多昔芬与雷洛昔芬治疗欧洲绝经后骨质疏松症的成本效果比较。
Osteoporos Int. 2014 Jan;25(1):325-37. doi: 10.1007/s00198-013-2521-4. Epub 2013 Oct 10.
9
Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model.基于 FRAX 模型的中国绝经后妇女干预阈值设定策略比较。
Endocrine. 2019 Jul;65(1):200-206. doi: 10.1007/s12020-019-01951-8. Epub 2019 May 20.
10
Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.巴泽多昔芬联合 FRAX®算法的成本效益：欧洲视角。
Osteoporos Int. 2011 Mar;22(3):955-65. doi: 10.1007/s00198-010-1291-5. Epub 2010 Jun 8.
引用本文的文献
1
Comparing the Effects of Dairy and Soybean on Bone Health in Women: A Food- and Component-Level Network Meta-Analysis.比较乳制品和大豆对女性骨骼健康的影响：一项食物及成分水平的网状Meta分析。
Nutrients. 2025 Aug 30;17(17):2833. doi: 10.3390/nu17172833.
2
10-Year Fracture Risk Assessment with Novel Adjustment (FRAXplus): Type 2 Diabetic Sample-Focused Analysis.采用新型调整方法的10年骨折风险评估（FRAXplus）：以2型糖尿病样本为重点的分析。
Diagnostics (Basel). 2025 Jul 29;15(15):1899. doi: 10.3390/diagnostics15151899.
3
Association between timing of surgery and refracture after initial osteoporotic fractures.初次骨质疏松性骨折后手术时机与再骨折之间的关联。
Sci Rep. 2025 Jun 6;15(1):19925. doi: 10.1038/s41598-025-04672-3.
4
Exercise for Postmenopausal Bone Health - Can We Raise the Bar?绝经后骨骼健康的运动——我们能否提高标准？
Curr Osteoporos Rep. 2025 Apr 10;23(1):20. doi: 10.1007/s11914-025-00912-7.
5
PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.用于骨折风险的甲状旁腺激素1型受体激动剂：一项系统评价和网状Meta分析
Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07440-1.
6
Association between dietary inflammatory index and osteoporosis in the US population: evidence from NHANES 2003-2010.美国人群饮食炎症指数与骨质疏松症之间的关联：来自2003 - 2010年美国国家健康与营养检查调查（NHANES）的证据
Front Nutr. 2025 Jan 29;12:1508127. doi: 10.3389/fnut.2025.1508127. eCollection 2025.
7
Aromatase inhibitors and fracture prevention - do 2017 guidelines work in real world?芳香化酶抑制剂与骨折预防——2017年指南在现实世界中有效吗？
BJC Rep. 2024 May 1;2(1):36. doi: 10.1038/s44276-024-00059-5.
8
S-Equol Ameliorates Menopausal Osteoarthritis in Rats through Reducing Oxidative Stress and Cartilage Degradation.S-Equol 通过减轻氧化应激和软骨降解改善绝经后大鼠骨关节炎。
Nutrients. 2024 Jul 21;16(14):2364. doi: 10.3390/nu16142364.
9
Atypical Fracture of the Scapular Spine: A Case Report.肩胛冈非典型骨折：一例报告
Cureus. 2024 May 13;16(5):e60237. doi: 10.7759/cureus.60237. eCollection 2024 May.
10
Menopause modified the association of blood pressure with osteoporosis among gender: a large-scale cross-sectional study.绝经改变了性别与骨质疏松症之间血压的关联：一项大规模的横断面研究。
Front Public Health. 2024 May 2;12:1383349. doi: 10.3389/fpubh.2024.1383349. eCollection 2024.
本文引用的文献
1
European guidance for the diagnosis and management of osteoporosis in postmenopausal women.欧洲绝经后妇女骨质疏松症的诊断和管理指南。
Osteoporos Int. 2013 Jan;24(1):23-57. doi: 10.1007/s00198-012-2074-y. Epub 2012 Oct 19.
Zotero 插件